Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Allison J. Xu"'
Autor:
Allison J. Xu, David Maag, Melanie J. Schroeder Patterson, Paul Ellis, Uri S. Ladror, Damien B. Ready, Eric F. Johnson, Bruce W. Surber, Niru B. Soni, Ramesh Iyer, Yan Shi, Joann P. Palma, Larry R. Solomon, John E. Harlan, Thomas D. Penning, Cherrie K. Donawho, Xuesong Liu, Alexander R. Shoemaker
Publikováno v:
Clinical Cancer Research. 18:510-523
Purpose: PARP inhibitors are being developed as therapeutic agents for cancer. More than six compounds have entered clinical trials. The majority of these compounds are β-nicotinamide adenine dinucleotide (NAD+)-competitive inhibitors. One exception
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f44bc36c2fb7ff89c222a53617f900
https://doi.org/10.1158/1078-0432.ccr-11-1973
https://doi.org/10.1158/1078-0432.ccr-11-1973
